Valuation: Enovis Corporation

Market Cap 1.47B 1.34B 1.23B 1.12B 2.1B 136B 2.21B 15.01B 5.97B 74.32B 5.51B 5.4B 233B P/E 2026 *
-1,019x
P/E 2027 * 46.3x
Enterprise Value 2.77B 2.53B 2.33B 2.12B 3.97B 257B 4.17B 28.32B 11.26B 140B 10.4B 10.18B 440B EV / Sales 2026 *
1.19x
EV / Sales 2027 * 1.11x
Free-Float
98.35%
Yield 2026 *
-
Yield 2027 * -
1 day-2.90%
1 week-7.98%
Current month+27.93%
1 month+23.10%
3 months-2.71%
6 months-3.74%
Current year-4.39%
1 week 25.38
Extreme 25.38
28.37
1 month 19.83
Extreme 19.83
29.89
Current year 16.7
Extreme 16.7
31.66
1 year 16.7
Extreme 16.7
31.66
3 years 16.7
Extreme 16.7
65.03
5 years 16.7
Extreme 16.7
154.89
10 years 16.7
Extreme 16.7
164.01
Manager TitleAgeSince
Chief Executive Officer 61 12/05/2025
Director of Finance/CFO 47 01/01/2023
Chief Administrative Officer - 05/01/2026
Director TitleAgeSince
Director/Board Member 55 13/05/2008
Director/Board Member 67 21/09/2010
Chairman 64 21/05/2025
Date Insider Type Main position Quantity % Market Cap. Importance
9/30/26 A Free

Director

958 0.0017%
9/4/26 A Buy

Chief Administrative Officer

2,660 0.0047%
9/4/26 A Buy

Chief Executive Officer

13,035 0.0228%
Change 5-day change 1-year change 3-year change Capi.($)
-2.90%-7.98%-5.07%-50.12% 1.47B
-0.84%-5.09%-16.92%+1.78% 178B
-0.67%-2.84%+0.59%+32.97% 122B
-0.98%+0.12%-14.00%+7.16% 118B
-1.24%-4.25%-43.89%-1.12% 88.1B
-0.63%-5.55%-6.35%+73.06% 64.71B
+0.05%-2.41%+12.24%-8.94% 57.96B
-1.95%-3.98%-1.91%+42.98% 53.28B
-2.91%-4.35%-0.82%+38.03% 47.8B
-1.64%+1.50%+2.30%-1.14% 35.65B
Average -1.37%-3.16%-7.38%+13.47% 77B
Weighted average by Cap. -1.04%-2.98%-10.72%+17.32%

Financials

2026 *2027 *
Net sales 2.34B 2.13B 1.96B 1.78B 3.35B 216B 3.52B 23.87B 9.49B 118B 8.77B 8.58B 371B 2.45B 2.23B 2.05B 1.87B 3.51B 227B 3.68B 25B 9.94B 124B 9.18B 8.99B 389B
Net income -675K -615K -566K -515K -967K -62.51M -1.02M -6.89M -2.74M -34.14M -2.53M -2.48M -107M 23.68M 21.56M 19.87M 18.07M 33.91M 2.19B 35.64M 242M 96.11M 1.2B 88.83M 86.96M 3.76B
Net Debt 1.3B 1.19B 1.09B 995M 1.87B 121B 1.96B 13.31B 5.29B 65.91B 4.89B 4.79B 207B 1.24B 1.13B 1.04B 947M 1.78B 115B 1.87B 12.68B 5.04B 62.77B 4.66B 4.56B 197B
Projected Income Statement - Annual - Enovis Corporation
Logo Enovis Corporation
Enovis Corporation is a medical technology company. It is focused on developing clinically differentiated solutions by manufacturing and distributing high-quality medical devices with a range of products used for reconstructive surgery, rehabilitation, pain management and physical therapy. It operates through two segments: Prevention & Recovery and Reconstructive. The Prevention & Recovery segment provides orthopedic and recovery science solutions, including devices, software, and services across the patient care continuum from injury prevention to rehabilitation after surgery, injury, or from degenerative diseases. The Prevention & Recovery products are marketed under several brand names, such as DJO. The Reconstructive segment provides surgical implant solutions, offering a comprehensive suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and finger and surgical productivity tools. It also operates a Enovis Growth eXcellence business system (EGX).
Employees
7,802
Date Price Change Volume
20/11/26 $25.47 -2.90% 1,220,305
19/11/26 $26.23 -3.21% 788,663
18/11/26 $27.10 -0.44% 887,083
17/11/26 $27.22 -2.51% 1,106,430
16/11/26 $27.92 +0.87% 1,258,218
Trader
Investor
Global
Quality
ESG MSCI
A
MarketScreener Ratings - Enovis Corporation
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
13
Last Close Price
25.47USD
Average target price
37.83USD
Spread / Average Target
+48.54%
  1. Stock Market
  2. Stocks
  3. ENOV Stock